Related Experiment Video
Updated: Aug 4, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Light Therapy in Parkinson's Disease: Towards Mechanism-Based Protocols
Karim Fifel1, Aleksandar Videnovic2
1Department of Molecular Cell Biology, Neurophysiology Unit, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands; International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
Trends in Neurosciences
|March 29, 2018
Summary
Light therapy shows promise for improving motor and non-motor symptoms in Parkinson's disease (PD). Further research is needed to develop effective light treatment protocols for PD patients.
Area of Science:
- Neuroscience
- Photomedicine
- Parkinson's Disease Research
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting millions globally.
- Current treatments for PD primarily manage motor symptoms, with limited efficacy for non-motor and neuroprotective aspects.
- Emerging research explores light therapy as a novel therapeutic strategy for PD.
Purpose of the Study:
- To review the current evidence on the safety and efficacy of light therapy for Parkinson's disease.
- To discuss the potential benefits of light therapy for both motor and non-motor symptoms in PD.
- To identify critical research directions for developing mechanism-based light therapy protocols in PD.
Main Methods:
- Review of existing scientific literature on light therapy and Parkinson's disease.
- Analysis of studies investigating the effects of light on PD symptoms.
- Synthesis of findings to inform future research strategies.
Main Results:
- Preliminary evidence suggests light therapy may offer benefits for motor and non-motor symptoms in PD.
- The safety profile of light therapy in PD requires further investigation.
- Understanding the underlying mechanisms of light's effects is crucial.
Conclusions:
- Light therapy presents a promising avenue for adjunctive treatment in Parkinson's disease.
- Further basic, translational, and clinical research is essential to optimize light therapy protocols.
- Developing mechanism-based approaches will enhance the therapeutic potential of light for PD.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...